Today: 20 May 2026
Browse Category

NASDAQ:MLTX 29 September 2025 - 8 January 2026

Biotech Bombshell: MoonLake (MLTX) Shares Tumble 85% on Trial News – Is a $108 Price Target Still Real?

Biotech Bombshell: MoonLake (MLTX) Shares Tumble 85% on Trial News – Is a $108 Price Target Still Real?

MoonLake Immunotherapeutics shares plunged about 85% pre-market Monday after mixed Phase 3 VELA trial results, dropping from around $62 to under $8 and cutting market cap from $3.9 billion to $0.5 billion. The stock had surged days earlier on takeover rumors and clinical optimism. VELA-1 met its primary endpoint, but VELA-2 narrowly missed. Analyst sentiment turned sharply negative after the data release.
29 September 2025
·

Stock Market Today

  • Cocoa Prices Rise on Fund Short Covering amid Supply and Weather Concerns
    May 20, 2026, 7:09 AM EDT. Cocoa prices rebounded sharply on Tuesday, with July ICE NY cocoa up 3.06%, driven by fund short covering after a recent slump. The market faces mixed signals: an increased supply forecast from Ivory Coast, the world's largest producer, raised to 2.2 million metric tons (MMT) for 2025/26, weighs on prices, while concerns over a potential El Niño weather event threatening West African crops offer support. Cocoa stocks hit a 1.75-year high, but early signs of a below-average 2026/27 harvest and steady chocolate demand from major makers Hershey and Mondelez bolster the outlook. Additionally, disruptions from the Strait of Hormuz closure adding shipping and fertilizer costs further support prices amid tightening global supplies.

Latest articles

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

InMed Pharmaceuticals (INM) Stock Doubled on Mentari Merger — Why the Rally Is Already Being Tested

20 May 2026
InMed Pharmaceuticals shares fell 14.4% to $1.37 in early pre-market trading Wednesday, after surging 135% Tuesday on news of an all-stock merger with Mentari Therapeutics and a planned $290 million private placement. Pre-merger InMed shareholders are expected to own about 1.51% of the combined company, which will operate as Mentari Therapeutics and focus on migraine drug development.
Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

Micware Shares Swing Pre-Market After 26% Drop on Nasdaq Debut

20 May 2026
Micware shares jumped 97.7% to $9.33 in premarket U.S. trading Wednesday, rebounding above last week’s $8 IPO price after closing Tuesday at $4.72. A new SEC filing showed Toyota owns 11.6% of Micware’s ordinary shares. The Japanese automotive software firm raised $22.8 million in its Nasdaq debut last week.
Dow edges up while Nasdaq falls as bond worries drag on

Futures Edge Higher Ahead of Nvidia Earnings as Wall Street Watches Key Report

20 May 2026
Nasdaq 100 futures rose 0.73% and S&P 500 futures gained 0.35% ahead of Wednesday’s open, with Nvidia set to report earnings after the close. Options markets priced in a 6.5% swing for Nvidia, equal to about $355 billion in market value. In premarket trading, Nvidia shares rose 1.84%, while Micron, Intel, and AMD also advanced. Fed minutes are due at 2:00 p.m. EDT.
Go toTop